33.42
2.14%
0.70
시간 외 거래:
35.00
1.58
+4.73%
전일 마감가:
$32.72
열려 있는:
$32.6
하루 거래량:
339.43K
Relative Volume:
0.96
시가총액:
$1.06B
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
-90.32
EPS:
-0.37
순현금흐름:
$274.29M
1주 성능:
-5.16%
1개월 성능:
-20.16%
6개월 성능:
-10.90%
1년 성능:
+50.54%
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
2023-08-25 | 재확인 | Needham | Buy |
2023-05-02 | 재개 | Jefferies | Buy |
2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-01-11 | 재확인 | H.C. Wainwright | Buy |
2020-07-14 | 개시 | BWS Financial | Sell |
2020-05-27 | 개시 | Guggenheim | Neutral |
2020-02-19 | 재개 | Jefferies | Buy |
2019-10-30 | 재확인 | Needham | Buy |
2019-05-03 | 재개 | H.C. Wainwright | Buy |
2019-04-12 | 재개 | Janney | Buy |
2019-03-20 | 개시 | SunTrust | Hold |
2019-01-16 | 재확인 | Needham | Buy |
2018-03-08 | 재확인 | H.C. Wainwright | Buy |
2018-02-07 | 재확인 | Needham | Buy |
2017-12-05 | 재확인 | Needham | Buy |
2017-09-11 | 개시 | H.C. Wainwright | Buy |
2017-05-11 | 재확인 | Needham | Buy |
2016-09-13 | 개시 | Gabelli & Co | Buy |
2015-06-01 | 개시 | Jefferies | Buy |
2015-06-01 | 개시 | Needham | Buy |
2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Collegium Pharmaceutical is Now Oversold (COLL) - Nasdaq
Emerald Advisers LLC Acquires 177,129 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.60 Average Target Price from Analysts - Defense World
(COLL) Trading Report - Stock Traders Daily
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Collegium Pharmaceutical (COLL) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Allspring Global Investments Holdings LLC Has $3.08 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Assenagon Asset Management S.A. Sells 188,423 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - MSN
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards? - MSN
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - Simply Wall St
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com - MarketBeat
StockNews.com Downgrades Collegium Pharmaceutical (NASDAQ:COLL) to Buy - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
(COLL) Investment Report - Stock Traders Daily
Inspire Investing LLC Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by StockNews.com - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Short Interest Down 6.5% in September - MarketBeat
Sanctuary Advisors LLC Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Receives Neutral Rating from Piper Sandler - Defense World
SG Americas Securities LLC Has $707,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) Given "Neutral" Rating at Piper Sandler - MarketBeat
Collegium Pharmaceutical Inc [COLL] Records 50-Day SMA of $37.25 - Knox Daily
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance
Market Update: Collegium Pharmaceutical Inc (COLL) Sees Negative Movement, Closing at 36.64 - The Dwinnex
Collegium Pharmaceutical And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
(COLL) Investment Analysis - Stock Traders Daily
Millennium Management LLC Has $9.79 Million Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Keeping an Eye on Collegium Pharmaceutical Inc (COLL) After Insider Trading Activity - Knox Daily
70,964 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Acquired by Marshall Wace LLP - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by ProShare Advisors LLC - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Marshall Wace LLP Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Collegium Pharmaceutical stock hits all-time high of $41.04 By Investing.com - Investing.com Canada
Breakouts Boost These Three Stocks To All-Time Highs - Investor's Business Daily
Collegium Pharmaceutical (NASDAQ:COLL) Reaches New 12-Month HighTime to Buy? - MarketBeat
Collegium Pharmaceutical stock hits all-time high of $41.04 - Investing.com
Axa S.A. Takes Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) delivers shareholders solid 28% CAGR over 5 years, surging 5.1% in the last week alone - Simply Wall St
A new trading data show Collegium Pharmaceutical Inc (COLL) is showing positive returns. - SETE News
H.C. Wainwright’s latest rating for COLL stock - Knox Daily
Squarepoint Ops LLC Has $3.55 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Squarepoint Ops LLC Has $3.55 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Hsbc Holdings PLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Deerfield Management Company L.P. Series C Has $428,000 Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Maverick Capital Ltd. Has $1.28 Million Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Should We Be Delighted With Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 46%? - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):